Pharmaceutical Professionals Can Earn Large Financial Rewards For Properly Exposing Pharmaceutical Manufacturer Fraud by Pharmaceutical Professional Whistleblower Reward Lawyer Jason S. Coomer
Large financial rewards are being offered to pharmaceutical professionals that properly expose drug manufacturer fraud. These rewards can stem from supply chain fraud, pricing schemes, marketing fraud, Medicaid fraud, Medicare fraud, procurement fraud or other forms of pharmaceutical manufacturer fraud. By contacting a Pharmaceutical Professional Whistleblower Reward Lawyer, these pharmaceutical professionals can protect their identity while their cases are reviewed. For more information on a potential Pharmaceutical Professional Whistleblower Reward Lawsuits, please feel free to send an e-mail message to Pharmaceutical Professional Whistleblower Reward Lawyer Jason Coomer or use our submission form.
Pharmaceutical Manufacturer Fraud Is Estimated to Have Increased to over $1 Trillion Annually
Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $750 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications. It is estimated that approximately 10 to 25% of public health care procurement spending including drug contracts, medicines, pharmaceuticals, medical equipment, and medical devices is lost to drug manufacturer fraud. These acts include government supply chain fraud, official bribes, illegal kickbacks, and other illicit payment and fraud schemes.
Pharmaceutical Professionals Can Earn Large Rewards for Properly Exposing Pharmaceutical Manufacturer Fraud
Pharmaceutical professionals with original information of pharmaceutical fraud can earn large financial rewards for exposing large scale systematic fraud scheme including bribery and supply chain fraud. In cases where $1,000,000.00 in bribes are made to obtain a $900 million government contract or an increase of $900 million of a drug market, the pharmaceutical professional whistleblower may be entitled to 10 to 30% of the $900,000,000.00 and the $1,000,000.00 translating into an aware of over $90 million to $270 million.
In other cases where a drug manufacturer is committing large scale supply chain fraud and/or marketing fraud of $1 Billion dollars, a pharmaceutical professional that properly exposes the fraud can earn a reward of 15% to 35% $150 million to $350 million depending on the case.
The SEC and DOJ Are Cracking Down on Large Scale Pharmaceutical Manufacturer Fraud and Have Recovered Billions of Dollars
The Department of Justice announced that pharmaceutical companies Wyeth and Pfizer Inc. have agreed to pay $784.6 million to resolve allegations that Wyeth knowingly reported to the government false and fraudulent prices on two of its proton pump inhibitor (PPI) drugs, Protonix Oral and Protonix IV. Pfizer, which is headquartered in New York City, acquired New Jersey-based Wyeth in 2009, approximately three years after Wyeth had ended the conduct that gave rise to the settlement. Wyeth and Pfizer Agree to Pay $784.6 Million to Resolve Lawsuit Alleging That Wyeth Underpaid Drug Rebates to Medicaid - April 27, 2016.
The United States’ largest distributor of endoscopes and related equipment will pay $623.2 million to resolve criminal charges and civil claims relating to a scheme to pay kickbacks to doctors and hospitals, U.S. Attorney Paul J. Fishman of the District of New Jersey and Principal Deputy Assistant Attorney General Benjamin C. Mizer of the Justice Department’s Civil Division announced today. U.S. Attorney Fishman and Principal Deputy Assistant Attorney General David Bitkower of the Justice Department’s Criminal Division also announced that a subsidiary of the distributor will pay $22.8 million to resolve criminal charges relating to the Foreign Corrupt Practices Act (FCPA) in Latin America. Medical Equipment Company Will Pay $646 Million for Making Illegal Payments to Doctors and Hospitals in United States and Latin America - March 1, 2016.
According to Bloomberg news, "Johnson & Johnson (JNJ), the world’s second-biggest seller of medical products, will pay $70 million after admitting that the company bribed doctors in Europe and paid kickbacks in Iraq to win contracts and sell drugs and artificial joints." Johnson & Johnson Will Pay $70 Million Over Bribery Claims By Joshua Gallu and Alex Nussbaum - Apr 8, 2011 2:09 PM CT
International Pharmaceutical Professional Whistleblower Reward Lawyer Works With International Pharmaceutical Professionals Who Want to Expose International Pharmaceutical Fraud and Earn Financial Rewards
International Pharmaceutical Professionals who want to become whistleblowers often want to protect their identity and their careers. By working through an International Pharmaceutical Professional Whistleblower Reward Lawyer, an International Pharmaceutical Professional Whistleblower can have their claim confidentially reviewed and protect their identity. For more information on Whistleblower Reward Laws that allow International Whistleblowers to protect their identities and collect large financial rewards for properly exposing illegal bribes and other Foreign Corrupt Practices Act (FCPA) violations, please go to the following web page International Whistleblowers and Foreign Corrupt Practices Information Center.
Pharmaceutical Quality Assurance Fraud Whistleblower Lawsuits, Drug Safety Fraud Whistleblower Lawsuits, Adulterated Drug Whistleblower Lawsuits, Contaminated Drug Whistleblower Lawsuits, and Pharmaceutical Drug Calibration Fraud Whistleblower Lawsuits
As a result of corruption, fraud, and unethical practices in the medicines supply chain, many diverted, counterfeit and substandard medicines have been identified in international markets around the world. Thus, these corruption, fraud, and unethical practices in the medicines supply chain not only lead to reduced availability of medicines in health facilities due to diversion of medicines, but also increase the presence of adulterated drugs and unsafe or ineffective products on the market. As such, it is extremely important that international pharmaceutical whistleblowers including international medicine quality assurance whistleblowers, international pharmaceutical calibration fraud whistleblowers, and other medicines drug safety whistleblowers continue to step forward to blow the whistle on adulterated drugs that threaten the health and safety of the people taking medications. Because of the serious potential danger to the public including men, women, and children that can be caused by giving contaminated medications or improperly calibrated medications, it is vitally important that whistleblowers help make sure that medicines are properly calibrated and not contaminated or counterfeited.
The offer of large economic incentives to international contaminated medicines whistleblowers and international adulterated drug whistleblowers will help expose dangerous and counterfeit medicines in the medicines supply chain. For more information on this topic, please go to the following web page International Pharmaceutical Supply Chain Fraud.
International Pharmaceutical Representative Whistleblower Lawsuits, International Medical Device Representative Whistleblower Lawsuits, and International Drug Marketing Executive Whistleblower Lawsuits
International pharmaceutical representative whistleblowers, international medical device sales representative whistleblowers, and international drug marketing executive whistleblowers are stepping up and exposing international bribes, international kickbacks, and international illicit payments through foreign banks. The economic incentive for these international pharmaceutical representative whistleblowers, international medical device sale representative whistleblowers, and international drug marketing executive whistleblowers is that if they are an original source with special knowledge of fraud and are the first to file, they may receive a portion of the money that the government recovers.
There are several keys to a successful SEC Bounty Whistleblower Reward Under the Foreign Corrupt Practices Act including 1) obtaining original and specialized information of the illegal kickback, bribery scheme, or illicit payments, and 2) being the first to file regarding the illegal kickback, bribery scheme, or illicit payments.
Pharmaceutical Professional Whistleblower Reward Lawsuits and Pharmaceutical Professional Whistleblower Lawyers
If you are an international drug marketing representative, international drug marketing executive, international medical device marketing representative, international medical device marketing executive, public health administrator, medical doctor, or other professional with original source knowledge of a potential International Medicine Supply Chain Whistleblower Reward Lawsuit, International Drug Representative Whistleblower Reward Lawsuit, Drug Contract Bribe Whistleblower Lawsuit, Medication Contract Illegal Kickback Lawsuit, Pharmaceutical Representative Whistleblower Reward Lawsuit, and Drug Representative Foreign Corrupt Practices Act Lawsuit or Foreign Corrupt Practices Act violation that could lead to an International Whistleblower Reward Lawsuit, please contact an international foreign corrupt practice act whistleblower reward lawyer to help expose the wrongdoing and protect yourself.
Please feel free to send an e-mail message to Pharmaceutical Professional Whistleblower Reward Lawyer Jason Coomer or use our submission form for a confidential review of a potential whistleblower reward lawsuit.
Feel Free to Contact Us with any Questions
Associations
